Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperemesis Gravidarum Risk Reduction With Metformin
NCT07129473Phase 2Recruiting
- Sponsor
- University of Southern California
- Start
- Jul 2026
- Primary completion
- Mar 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in hyperemesis gravidarum (HG), sponsored by University of Southern California. Started Jul 2026; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
hyperemesis gravidarum (HG)
Beyond the preview
Go deeper on NCT07129473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07129473.